By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile

 

Viamet Pharmaceuticals 

406 Blackwell Street
Suite 200
Durham  North Carolina  27701-3984  U.S.A.
Phone: 919-969-7505 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Viamet Pharmaceuticals Announces Appointment Of Amir Tavakkol, Ph.D., As Chief Development Officer 7/22/2014 10:24:59 AM
Viamet Pharmaceuticals Reports Additional Positive Interim Results Of Phase 2 Studies Of VT-1161 With Moderate To Severe Interdigital Tinea Pedis 7/11/2014 11:04:25 AM
Viamet Pharmaceuticals Reports Additional Positive Interim Results Of Phase 2 Study Of VT-1161 In Patients With Moderate To Severe Acute Vulvovaginal Candidiasis 7/11/2014 9:20:05 AM
Durham Drug Developer Viamet Pharmaceuticals Files For $75 Million IPO 7/8/2014 7:22:35 AM
Viamet Pharmaceuticals Reports Positive Interim Results Of Phase 2 Interdigital Tinea Pedis Study Of VT-1161 3/12/2014 8:16:59 AM
Viamet Pharmaceuticals Reports Positive Interim Results Of Phase 2 Study Of VT-1161 2/19/2014 7:20:49 AM
Viamet Pharmaceuticals To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/8/2014 10:38:05 AM
Viamet Pharmaceuticals Expands Phase 2 Clinical Program With Novel Antifungal Agent VT-1161 9/24/2013 9:48:20 AM
Viamet Pharmaceuticals Initiates Phase 2 Clinical Program With Novel Antifungal Agent VT-1161 9/6/2013 10:07:09 AM
Viamet Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference 1/3/2013 8:22:49 AM
123
//-->